BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17121466)

  • 21. Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells.
    Palhais B; Præstegaard VS; Sabaratnam R; Doktor TK; Lutz S; Burda P; Suormala T; Baumgartner M; Fowler B; Bruun GH; Andersen HS; Kožich V; Andresen BS
    Nucleic Acids Res; 2015 May; 43(9):4627-39. PubMed ID: 25878036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of exon identity is a common mechanism of human inherited disease.
    Sterne-Weiler T; Howard J; Mort M; Cooper DN; Sanford JR
    Genome Res; 2011 Oct; 21(10):1563-71. PubMed ID: 21750108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ETFDH c.158A>G variation disrupts the balanced interplay of ESE- and ESS-binding proteins thereby causing missplicing and multiple Acyl-CoA dehydrogenation deficiency.
    Olsen RK; Brøner S; Sabaratnam R; Doktor TK; Andersen HS; Bruun GH; Gahrn B; Stenbroen V; Olpin SE; Dobbie A; Gregersen N; Andresen BS
    Hum Mutat; 2014 Jan; 35(1):86-95. PubMed ID: 24123825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiated evolutionary rates in alternative exons and the implications for splicing regulation.
    Plass M; Eyras E
    BMC Evol Biol; 2006 Jun; 6():50. PubMed ID: 16792801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants.
    Pettigrew CA; Wayte N; Wronski A; Lovelock PK; Spurdle AB; Brown MA
    Breast Cancer Res Treat; 2008 Jul; 110(2):227-34. PubMed ID: 17899372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with a purine-rich exonic splicing enhancer sequence in Xenopus oocyte nucleus.
    Masuyama K; Taniguchi I; Okawa K; Ohno M
    Biochem Biophys Res Commun; 2007 Aug; 359(3):580-5. PubMed ID: 17548051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of purine-rich exonic splicing enhancers in nuclear retention of pre-mRNAs.
    Taniguchi I; Masuyama K; Ohno M
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13684-9. PubMed ID: 17699631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons.
    Fairbrother WG; Yeo GW; Yeh R; Goldstein P; Mawson M; Sharp PA; Burge CB
    Nucleic Acids Res; 2004 Jul; 32(Web Server issue):W187-90. PubMed ID: 15215377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.
    Zheng ZM
    J Biomed Sci; 2004; 11(3):278-94. PubMed ID: 15067211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-mRNA secondary structures influence exon recognition.
    Hiller M; Zhang Z; Backofen R; Stamm S
    PLoS Genet; 2007 Nov; 3(11):e204. PubMed ID: 18020710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
    Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
    Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in sequence and organization of splicing regulatory elements in vertebrate genes.
    Yeo G; Hoon S; Venkatesh B; Burge CB
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15700-5. PubMed ID: 15505203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of disease-associated HRPT2 mutations on splicing.
    Hahn MA; McDonnell J; Marsh DJ
    J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms.
    Pettigrew C; Wayte N; Lovelock PK; Tavtigian SV; Chenevix-Trench G; Spurdle AB; Brown MA
    Breast Cancer Res; 2005; 7(6):R929-39. PubMed ID: 16280041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas.
    Tanimoto K; Muramatsu T; Inazawa J
    Cancer Med; 2019 Dec; 8(17):7372-7384. PubMed ID: 31631560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper-binding proteins and exonic splicing enhancers and silencers.
    Bakhtiar D; Vorechovsky I
    Metallomics; 2024 May; 16(5):. PubMed ID: 38692844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coevolutionary networks of splicing cis-regulatory elements.
    Xiao X; Wang Z; Jang M; Burge CB
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18583-8. PubMed ID: 17998536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of splicing enhancer activities by RNA secondary structures.
    Liu W; Zhou Y; Hu Z; Sun T; Denise A; Fu XD; Zhang Y
    FEBS Lett; 2010 Nov; 584(21):4401-7. PubMed ID: 20888818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Searching for splicing motifs.
    Chasin LA
    Adv Exp Med Biol; 2007; 623():85-106. PubMed ID: 18380342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A computational survey of candidate exonic splicing enhancer motifs in the model plant Arabidopsis thaliana.
    Pertea M; Mount SM; Salzberg SL
    BMC Bioinformatics; 2007 May; 8():159. PubMed ID: 17517127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.